Radionuclide assessment infarct size ventricular function clinical trials thrombolysis Mortality ventricular ejection fraction infarct size important end points efficiency thrombolytic treatment clinical trials Radionuclide assessment ejection fraction infarct size safe accurate reproducible available use clinical trials supplements mortality data allows meaningful results trials patient numbers Single photon emission tomography detection quantification infarct size use new radiopharmaceuticals important role future trials period techniques Western Washington Thrombolysis Trials infarct size ejection fractions patients streptokinase tissue-type plasminogen activator recent trial direct relation end points time symptom onset initiation treatment Future trials efforts treatment first hour symptom onset observation 